Ingram Douglas S is President & CEO of Sarepta Therapeutics Inc.
Person profile
Roles
Sarepta Therapeutics
President & CEO
Relay Therapeutics
Director
Address
Irvine, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sarepta Therapeutics, Inc.
6 Nov 23
4
Relay Therapeutics, Inc.
1 Jun 23
4
Relay Therapeutics, Inc.
27 May 22
4
Sarepta Therapeutics, Inc.
17 Nov 21
4
Sarepta Therapeutics, Inc.
28 Jun 21
4
Relay Therapeutics, Inc.
21 May 21
4
Sarepta Therapeutics, Inc.
4 Jan 21
4
Relay Therapeutics, Inc.
21 Jul 20
3
Relay Therapeutics, Inc.
15 Jul 20
4
Sarepta Therapeutics, Inc.
3 Jan 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Nov 23 | SRPT Sarepta Therapeutics | Common Stock | Buy | Acquire P | No | No | 81.26 | 200 | 16.25 k | 390,307 |
3 Nov 23 | SRPT Sarepta Therapeutics | Common Stock | Buy | Acquire P | No | No | 80.33 | 3,884 | 312.00 k | 390,107 |
3 Nov 23 | SRPT Sarepta Therapeutics | Common Stock | Buy | Acquire P | No | No | 79.7 | 11,060 | 881.48 k | 386,223 |
3 Nov 23 | SRPT Sarepta Therapeutics | Common Stock | Buy | Acquire P | No | No | 78.57 | 10,081 | 792.06 k | 375,163 |
31 May 23 | RLAY Relay Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.14 | 66,055 | 735.85 k | 66,055 |